Clinical Trial Update: Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib in combination with vinorelbine for advanced non-small cell lung cancer with non-driver gene mutations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Yongchang Zhang | Conditions: Advanced Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED